Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Solid Biosciences $240 million private placement
We advised the lead placement agents
Korro Bio $85 million private placement
We advised the placement agents
Abbott Laboratories $20 billion notes offering
We advised the joint book-running managers on the offering
Oculis Holding $100 million at-the-market offering
We advised the sales agent on the offering
MiniMed $560 million IPO
The carve-out IPO of Medtronic’s diabetes unit is the second largest medtech IPO ever
AbbVie $8 billion senior notes offering
We advised the representatives of the underwriters on the offering
Alignment Healthcare $256 million secondary offering
We advised the underwriter on the offering
One Call acquisition of Data Dimensions
We are advising One Call on the transaction
Tandem Diabetes Care $300 million convertible senior notes offering
We advised the representatives of the initial purchasers on the offering
Revolution Medicines $1 billion at-the-market offering
We advised the sales agent on the offering